Quark Pharmaceuticals Reports Favorable Results From Phase II Clinical Trial Evaluating Investigational siRNA QPI-1002

World News: . []

SAN FRANCISCO July 28 2014 GLOBE NEWSWIRE -- Today Quark Pharmaceuticals Inc LINK  data from a randomized double-blinded placebo-controlled multicenter Phase II clinical trial QRK006B of LINK  a synthetic chemically modified siR NA acti...

More news and information about Quark Pharmaceuticals, Inc. USA.

Published By:

Globe Newswire: 16:00 GMT Monday 28th July 2014

Published: .

Search for other references to "quark" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us